Sponsor:
Nova Scotia Health Authority
Code:
NCT03601026
Conditions
Mental Illness
Schizophrenia
Bipolar Disorder
Major Depressive Disorder
Cannabis Use
Eligibility Criteria
Sex: All
Age: 12 - 21
Healthy Volunteers: Not accepted
Interventions
Genetic counselling
Brief summary:
Conditions
Mental Illness
Schizophrenia
Bipolar Disorder
Major Depressive Disorder
Cannabis Use
Study ID
NCT03601026
Start date
Nov 1, 2019
Status verified date
May, 2025
Completion date
Sep 1, 2027
Anticipated
Primary completion date
Sep 1, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 12 - 21
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Genetic counselling
no intervention: Control group
Interventions
Genetic counselling
Primary outcome measure
Central contacts
Locations
Nova Scotia Health Authority
Recruiting
Halifax, Nova Scotia, Canada, B3H 2E2
Contacts
Rudolf Uher, MD PhD
uher@dal.caJill Cumby, RN
jill.cumby@nshealth.caSponsor
Nova Scotia Health Authority
Last update posted
May 14, 2025
Last verified
May, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Nova Scotia Health Authority on 2025-05-14.